During the past decade, DERMING conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "DERMING" are "Malar and Sub-malar Volume Deficiency" (2 trials), "Atopic Dermatitis" (1 trials), "Dry and Damaged Skin" (1 trials), "Face Aging/Photo Aging of Moderate Grade" (1 trials) and "Face Photoaging" (1 trials). Many other conditions were trialed in "DERMING" in a lesser frequency.

Most popular intervention types in "DERMING" are "Device" (9 trials), "Other" (6 trials), "Dietary Supplement" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "P927 - LICHTENA DermAD CREMA CORPO" (2 trials), "Profhilo®" (2 trials), ""SUNEKOS® 1200" and "SUNEKOS® 200"" (1 trials), "Actapil Corpo Spray (SHEDIR PHARMA Srl - Italy)" (1 trials) and "Aliaxin (new trademark - IBSA Farmaceutici Italia S.r.l.)" (1 trials). Other intervention names were less common.

The vast majority of trials in "DERMING" are 14 trials for "Female" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "DERMING". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in DERMING, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in DERMING, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 16 trials that are defined as “Not Applicable".